2015, Number 2
<< Back Next >>
Rev Cubana Estomatol 2015; 52 (2)
Oral monitoring of a pediatric patient during chemotherapy treatment
Arrais RIL, Gondim VAM, Ferreti BPR, Galbiatti de Carvalho CF
Language: English
References: 12
Page: 196-201
PDF size: 93.79 Kb.
ABSTRACT
Oral side effects must be expected during cancer treatment on pediatric patients.
Monitoring side effects on oral cavity of antineoplastic therapy is desirable but
sometimes performed without criteria. The purpose of this article is to describe an
oral monitoring in an male with Hodgkin lymphoma during chemotherapy treatment
using an Oral Assessment Guide. An 11-yr-old male was assisted during all
treatment of chemotherapy against Hodgkin's lymphoma in the dental sector of a
hospital of reference of João Pessoa, Paraíba, Brazil. The Oral Assessment Guide
was applied by a calibrate examiner and was observed the emergence of ulcerative
lesions on the labial mucosa emerged on two different periods (D15- primary cycle;
D15-second cycle) and the major values of oral mucositis were verified in D1 e D15
periods of second cycle of chemotherapy. Monitoring oral side effects during
antineoplastic therapy could prevent severe oral complications and avoid to
associate systemic complications.
REFERENCES
Chen CF, Wang RH, Cheng SN, Chang YC. Assessment of chemotherapy-induced oral complications in children with cancer. J Pediatr Oncol Nurs. 2004;21(1):33-9.
Jensen SB, Peterson DE. Oral mucosal injury caused by cancer therapies: current management and new frontiers in research. Journal of Oral Pathology & Medicine. 2014;43(2):81-90.
Lopes IA, Nogueira DN, Lopes IA. Oral manifestations of chemotherapy in children from a cancer treatment center. 2012;12(1):113-9.
Eilers J, Berger AM, Peterson MC. Development, testing, and application of the oral assessment. Oncol Nurs Forum. 1988;15:325-30.
Cheng KKF, Chang AM, Yuenc MP. Prevention of oral mucositis in paediatric patients treated with chemotherapy: a randomised crossover trial comparing two protocols of oral care. European Journal of Cancer. 2004;40:1208–16.
Dhillon J, Kalra GK, Mathur V. Oral health in children with leucemia. Indian Journal of Palliative Care. 2012;18(1):12-8.
Kutob AF, Gue S, Revesz T, Logan RM, Keefe D. Prevention of oral mucositis in children receiving cancer therapy: A systematic review and evidence-based analysis. 2013;49(2):102-7.
Barbosa AM, Ribeiro DM, Caldo-Teixeira AS. Conhecimentos e práticas em saúde bucal com crianças hospitalizadas com câncer. Ciência & Saúde Coletiva. 2010;15(1):1113-22.
Sonis ST. The Epidemiology and Risk Assessment of Mucositis. Oral mucositis. 2012:15-24.
Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009;45(12):1015-20.
Cheng KKF, Lee V, Li CH, Goggins W, Thompson DR, Yuen HL, et al. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncology. 2011;47(3):153–62.
Valéra M-C, Noirrit-Esclassan M, Pasquet M, Vaysse F. Oral complications and dental care in children with acute lymphoblastic leukaemia. Journal of Pathology & Medicine. 2014;43(8):122-6.